Funding for this research was provided by:
U.S. Department of Veterans Affairs
Implementation Research Institute
Quality Enhancement Research Initiative (PEC 19-307)
Agency for Healthcare Research and Quality (K12HS019461)
National Institute on Drug Abuse (K23DA048182)
National Institute of Mental Health (K01MH113806)
Received: 17 February 2021
Accepted: 19 November 2021
First Online: 18 December 2021
: Not applicable. The VA Pittsburgh Healthcare System IRB reviewed the evaluation protocol and deemed it to be a non-research operations activity per VHA Handbook 1058.05/VHA Program Guide 1200.21.
: Not applicable.
: Dr. Morgan has received grants to the institution for clinical trials from Genfit, Abbvie, Merck, and Gilead Sciences. All other authors declare no competing interests.